Skip to main content
logo
Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
1.400
+0.030 (2.19%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Purple Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
611237
Market Cap Growth
-18.59%-49.60%-38.40%-22.81%-63.17%5.60%
Enterprise Value
-0.41-8.77-7.08-13-28.86-39.25
Last Close Price
1.400.664.6915.6027.6077.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----1.1577.03
PB Ratio
0.630.060.040.060.050.11
P/TBV Ratio
0.420.130.150.280.9520.18

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
-0.320.650.591.292.22
EV/EBIT Ratio
-0.320.640.581.282.19
EV/FCF Ratio
-1.550.490.651.722.62

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-000.000.010.01
Net Debt / Equity Ratio
-0.64-0.96-0.25-0.44-0.67-0.72
Net Debt / EBITDA Ratio
0.220.340.770.681.412.62
Net Debt / FCF Ratio
0.921.650.580.761.893.10
Quick Ratio
1.401.232.141.594.5511.11
Current Ratio
1.481.272.231.634.7111.41
Return on Equity (ROE)
-269.77%-138.78%-41.55%-66.27%-38.79%-24.61%
Return on Assets (ROA)
-176.94%-100.56%-27.06%-45.03%-36.22%-23.29%
Return on Invested Capital (ROIC)
-1508.93%-220.56%-50.24%-128.23%-132.35%-86.44%
Return on Capital Employed (ROCE)
-288.14%-128.10%-32.53%-54.21%-39.82%-24.46%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
----86.85%1.30%
Buyback Yield / Dilution
-230.28%-192.79%-48.15%87.76%92.14%0.00%
Total Shareholder Return
-230.28%-192.79%-48.15%87.76%92.14%0.00%
SEC Filings: 10-K · 10-Q